These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

766 related items for PubMed ID: 26873006

  • 1. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M, Fukahori M, Ikemura A, Kubota A, Higashino H, Sakuma S, Yamashita S.
    Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of food intake on the oral absorption of poorly water-soluble drugs: in vitro assessment of drug dissolution and permeation assay system.
    Kataoka M, Masaoka Y, Sakuma S, Yamashita S.
    J Pharm Sci; 2006 Sep; 95(9):2051-61. PubMed ID: 16850428
    [Abstract] [Full Text] [Related]

  • 4. In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs.
    Kataoka M, Masaoka Y, Yamazaki Y, Sakane T, Sezaki H, Yamashita S.
    Pharm Res; 2003 Oct; 20(10):1674-80. PubMed ID: 14620525
    [Abstract] [Full Text] [Related]

  • 5. An in vitro system for prediction of oral absorption of relatively water-soluble drugs and ester prodrugs.
    He X, Sugawara M, Kobayashi M, Takekuma Y, Miyazaki K.
    Int J Pharm; 2003 Sep 16; 263(1-2):35-44. PubMed ID: 12954178
    [Abstract] [Full Text] [Related]

  • 6. Assessment of absorption potential of poorly water-soluble drugs by using the dissolution/permeation system.
    Kataoka M, Yano K, Hamatsu Y, Masaoka Y, Sakuma S, Yamashita S.
    Eur J Pharm Biopharm; 2013 Nov 16; 85(3 Pt B):1317-24. PubMed ID: 23811221
    [Abstract] [Full Text] [Related]

  • 7. Application of an In Vitro Dissolution/Permeation System to Early Screening of Oral Formulations of Poorly Soluble, Weakly Basic Drugs Containing an Acidic pH-Modifier.
    Mizoguchi M, Kataoka M, Yokoyama K, Aihara R, Wada K, Yamashita S.
    J Pharm Sci; 2018 Sep 16; 107(9):2404-2410. PubMed ID: 29802932
    [Abstract] [Full Text] [Related]

  • 8. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs.
    Higashino H, Hasegawa T, Yamamoto M, Matsui R, Masaoka Y, Kataoka M, Sakuma S, Yamashita S.
    Mol Pharm; 2014 Mar 03; 11(3):746-54. PubMed ID: 24460473
    [Abstract] [Full Text] [Related]

  • 9. The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulations.
    Sugawara M, Kadomura S, He X, Takekuma Y, Kohri N, Miyazaki K.
    Eur J Pharm Sci; 2005 Sep 03; 26(1):1-8. PubMed ID: 15961297
    [Abstract] [Full Text] [Related]

  • 10. Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract.
    Kobayashi M, Sada N, Sugawara M, Iseki K, Miyazaki K.
    Int J Pharm; 2001 Jun 19; 221(1-2):87-94. PubMed ID: 11397570
    [Abstract] [Full Text] [Related]

  • 11. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y, Takeuchi S, Matsui K, Amidon GE, Amidon GL.
    Eur J Pharm Sci; 2015 Aug 30; 76():203-12. PubMed ID: 25978875
    [Abstract] [Full Text] [Related]

  • 12. In vitro dissolution/permeation system to predict the oral absorption of poorly water-soluble drugs: effect of food and dose strength on it.
    Kataoka M, Itsubata S, Masaoka Y, Sakuma S, Yamashita S.
    Biol Pharm Bull; 2011 Aug 30; 34(3):401-7. PubMed ID: 21372392
    [Abstract] [Full Text] [Related]

  • 13. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
    Takano R, Sugano K, Higashida A, Hayashi Y, Machida M, Aso Y, Yamashita S.
    Pharm Res; 2006 Jun 30; 23(6):1144-56. PubMed ID: 16715363
    [Abstract] [Full Text] [Related]

  • 14. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E, Westergren J, Grant I, Hanisch G, Lindfors L, Lennernäs H, Abrahamsson B, Tannergren C.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):679-98. PubMed ID: 23727464
    [Abstract] [Full Text] [Related]

  • 15. Improved dissolution and absorption of ketoconazole in the presence of organic acids as pH-modifiers.
    Adachi M, Hinatsu Y, Kusamori K, Katsumi H, Sakane T, Nakatani M, Wada K, Yamamoto A.
    Eur J Pharm Sci; 2015 Aug 30; 76():225-30. PubMed ID: 25988287
    [Abstract] [Full Text] [Related]

  • 16. In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.
    Li ZQ, Tian S, Gu H, Wu ZG, Nyagblordzro M, Feng G, He X.
    AAPS PharmSciTech; 2018 May 30; 19(4):1882-1893. PubMed ID: 29663288
    [Abstract] [Full Text] [Related]

  • 17. Application of dissolution/permeation system for evaluation of formulation effect on oral absorption of poorly water-soluble drugs in drug development.
    Kataoka M, Sugano K, da Costa Mathews C, Wong JW, Jones KL, Masaoka Y, Sakuma S, Yamashita S.
    Pharm Res; 2012 Jun 30; 29(6):1485-94. PubMed ID: 22134778
    [Abstract] [Full Text] [Related]

  • 18. Predicting the Changes in Oral Absorption of Weak Base Drugs Under Elevated Gastric pH Using an In Vitro-In Silico-In Vivo Approach: Case Examples-Dipyridamole, Prasugrel, and Nelfinavir.
    Kambayashi A, Dressman JB.
    J Pharm Sci; 2019 Jan 30; 108(1):584-591. PubMed ID: 30423339
    [Abstract] [Full Text] [Related]

  • 19. Estimation of P-glycoprotein-mediated efflux in the oral absorption of P-gp substrate drugs from simultaneous analysis of drug dissolution and permeation.
    Kataoka M, Yokoyama T, Masaoka Y, Sakuma S, Yamashita S.
    Eur J Pharm Sci; 2011 Nov 20; 44(4):544-51. PubMed ID: 21963456
    [Abstract] [Full Text] [Related]

  • 20. An enteric polymer mitigates the effects of gastric pH on oral absorption of poorly soluble weak acid drugs from supersaturable formulations: A case study with dantrolene.
    Kataoka M, Nakanishi R, Umesaki M, Kobayashi M, Minami K, Higashino H, Yamaguchi S, Yamashita S.
    Eur J Pharm Biopharm; 2020 Oct 20; 155():29-36. PubMed ID: 32771692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.